BMP-2 gene polymorphisms and osteoporosis: The Rotterdam study

Journal of Bone and Mineral Research

Volumn 21, Issue 6, 2006, Pages 845-854

  Medici, Marco ^a   Van Meurs, Joyce B J ^a   Rivadeneira, Fernando ^a   Zhao, HongYan ^a   Arp, Pascal P ^a   Hofman, Albert ^a   Pols, Huibert A P ^a   Uitterlinden, André G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Association; Fractures; Genetic; Haplotypes; Polymorphism

Indexed keywords

ALANINE; ARGININE; BONE MORPHOGENETIC PROTEIN 2; SERINE;

ADULT; AGED; ALLELE; ANALYSIS OF COVARIANCE; ARTICLE; BMP2 GENE; BONE DENSITY; BONE STRUCTURE; CELL DIFFERENTIATION; CHINESE; CORIELL PANEL; DATA ANALYSIS SOFTWARE; ETHNIC GROUP; FEMALE; FEMUR NECK; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NEGRO; NETHERLANDS; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PARAMETER; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN FUNCTION; RISK ASSESSMENT; STRUCTURE ANALYSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MORPHOGENETIC PROTEINS; COHORT STUDIES; DATABASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; NETHERLANDS; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; VARIATION (GENETICS);

EID: 33646864811     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060306     Document Type: Article

References (46)

1. Uitterlinden AG, van Leeuwen JP, Pols HA 2001 Genetics and genomics of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis, 2nd ed., vol. 1. Academic Press, San Diego, CA, USA, pp. 639-667.
2. Kelly PJ, Harris M 1995 Genetic regulation of peak bone mass. Acta Paediatr Suppl 411:24-30.
3. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:706-710.
4. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017-2022.
5. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773.
6. Flicker L, Faulkner KG, Hopper JL, Green RM, Kaymacki B, Nowson CA, Young D, Wark JD 1996 Determinants of hip axis length in women aged 10-89 years: A twin study. Bone 18:41-45.
7. Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME 2004 Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 75:1032-1045.
8. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP 2004 Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143-156.
9. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG 2003 Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632-1641.
10. Pluijm SM, van Essen HW, Bravenboer N, Uitterlinden AG, Smit JH, Pols HA, Lips P 2004 Collagen type I alpha 1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women. Ann Rheum Dis 63:71-77.
11. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH 1998 Relation of alleles of the collagen type I alpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016-1021.
12. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, Mc Guigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG, Study GENOMOS 2004 Differential gene effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105-2114.
13. Boot AM, van der Sluis IM, de Muinck Keizer-Schrama SM, van Meurs JB, Krenning EP, Pols HA, Uitterlinden AG 2004 Estrogen receptor alpha gene and bone mineral density in healthy children and young adults. Calcif Tissue Int 74:495-500.
14. Liu YZ, Liu YJ, Recker RR, Deng HW 2003 Molecular studies of identification of genes for osteoporosis: The 2002 update. J Endocrinol 177:147-196.
15. Ralston SH 2002 Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460-2466.
16. Kanzler B, Foreman RK, Labosky PA, Mallo M 2000 BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development 127:1095-1104.
17. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G 2001 Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 29:323-330.
18. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V 1992 Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324.
19. Zhang H, Bradley A 1996 Mice deficient for BMP2 are non-viable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986.
20. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338.
21. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE 1998 Differential roles for bone morphogenetic protein (BMP) receptor type 1B and 1A in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
22. Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K 2003 Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res 18:1854-1862.
23. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T 1995 Enhanced expression of type 1 receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:1651-1659.
24. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dijke P, Sakou T 1998 Distinc and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type 2 receptor during fracture healing in rats. Bone 22:605-612.
25. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S 2003 BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853.
26. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T 1997 Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580.
27. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241.
28. Miyazono K 2000 TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 11:15-22.
29. Ebara S, Nakayama K 2002 Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27:S10-S15.
30. Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir VD, Sigurdardottir MS, Bagger Y, Christiansen C, Reynisdottir I, Grant SF, Jonasson K, Frigge ML, Gulcher JR, Sigurdsson G, Stefansson K 2003 Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 1:E69.
31. Reneland RH, Mah S, Kammere S, Hoyal CR, Marnellos G, Wilson SG, Sambrook PN, Spector TD, Nelson MR, Braun A 2005 Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 6:9.
32. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA 1991 Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403-422.
33. Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, van Kuijk C, Schutte HE, Birkenhager JC, Pols HA 1994 The association between age and bone mineral density in men and women aged 55 years and over: The Rotterdam Study. Bone Miner 25:1-13.
34. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW 2000 Structural trends in the aging femoral neck and proximal shaft: Analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15:2297-2304.
35. Beck TJ, Ruff CB, Mourtada FA, Shaffer RA, Maxwell-Williams K, Kao GL, Sartoris DJ, Brodine S 1996 Dual-energy X-ray absorptiometry derived structural geometry for stress fracture prediction in male U.S. Marine Corps recruits. J Bone Miner Res 11:645-653.
36. Beck TJ, Ruff CB, Warden KE, Scott WW Jr, Rao GU 1990 Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol 25:6-18.
37. Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, van Duijn CM, Uitterlinden AG 2004 The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: The Rotterdam Study. J Bone Miner Res 19:1280-1290.
38. Schoofs MWCJ, van der Klift M, Hofman A, van Duijn CM, Stricker BHCh, Pols HAP, Uitterlinden AG 2004 ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: The Rotterdam Study. J Bone Miner Res 19:1490-1496.
39. Cooper C 1993 The epidemiology of fragility fractures: Is there a role for bone quality? Calcif Tissue Int 53:S23-S26.
40. van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA 2002 The incidence of vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 17:1051-1056.
41. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA 1993 The assessment of vertebral deformity: A method for use in population studies and clinical trials. Osteoporos Int 3:138-147.
42. Stephens M, Smith NJ, Donnelly P 2001 A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
43. Schlesselman JJ 1982 Sample size. In: Schlesselman JJ (ed.) Case-Control Studies: Design, Conduct, Analysis, 1st ed. Oxford University Press, New York, NY, USA, pp. 144-152.
44. Huang QY, Recker RR, Deng HW 2003 Searching for osteoporosis genes in the post-genome era: Progress and challenges. Osteoporos Int 14:701-715.
45. Ralston SH, Galwey N, MacKay I, Albagha OM, Cardon L, Compston JE, Cooper C, Duncan E, Keen R, Langdahl B, McLellan A, O'Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass J, Bennett ST 2005 Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: The FAMOS study. Hum Mol Genet 14:943-951.
46. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG 2001 Replication validity of genetic association studies. Nat Genet 29:306-309.